أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - risperidone, quantity: 6 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; lactose monohydrate; quinoline yellow; maize starch; hypromellose; magnesium stearate; titanium dioxide; macrogol 400 - risperidone is indicated for the treatment of schizophrenia and related psychoses. risperidone is indicated for the treatment of behavioural disturbances in dementia. risperidone is indicated for the treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - risperidone, quantity: 4 mg - tablet, film coated - excipient ingredients: maize starch; colloidal anhydrous silica; microcrystalline cellulose; magnesium stearate; lactose monohydrate; indigo carmine; quinoline yellow; hypromellose; titanium dioxide; macrogol 400 - risperidone is indicated for the treatment of schizophrenia and related psychoses. risperidone is indicated for the treatment of behavioural disturbances in dementia. risperidone is indicated for the treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - risperidone -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - risperidone, quantity: 3 mg - tablet, film coated - excipient ingredients: maize starch; magnesium stearate; hypromellose; lactose monohydrate; colloidal anhydrous silica; quinoline yellow; microcrystalline cellulose; titanium dioxide; macrogol 400 - risperidone is indicated for the treatment of schizophrenia and related psychoses. risperidone is indicated for the treatment of behavioural disturbances in dementia. risperidone is indicated for the treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - risperidone -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - risperidone, quantity: 2 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; quinoline yellow; maize starch; colloidal anhydrous silica; lactose monohydrate; iron oxide red; hypromellose; titanium dioxide; macrogol 400 - risperidone is indicated for the treatment of schizophrenia and related psychoses. risperidone is indicated for the treatment of behavioural disturbances in dementia. risperidone is indicated for the treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - risperidone -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - risperidone, quantity: 1 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; hypromellose; maize starch; titanium dioxide; macrogol 400 - risperidone is indicated for the treatment of schizophrenia and related psychoses. risperidone is indicated for the treatment of behavioural disturbances in dementia. risperidone is indicated for the treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - risperidone -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - risperidone, quantity: 0.5 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; maize starch; hypromellose; microcrystalline cellulose; lactose monohydrate; magnesium stearate; iron oxide red; titanium dioxide; macrogol 400 - risperidone is indicated for the treatment of schizophrenia and related psychoses. risperidone is indicated for the treatment of behavioural disturbances in dementia. risperidone is indicated for the treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent.